Pediatrix Medical Group, Inc. $MD Shares Sold by CastleKnight Management LP

Posted by Francis Steltz on Jun 18th, 2026

CastleKnight Management LP cut its stake in Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 41.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 396,066 shares of the company’s stock after selling 285,934 shares during the period. CastleKnight Management LP owned 0.46% of Pediatrix Medical Group worth $8,472,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Global Retirement Partners LLC boosted its stake in Pediatrix Medical Group by 68,250.0% in the 4th quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock worth $29,000 after purchasing an additional 1,365 shares in the last quarter. Transamerica Financial Advisors LLC acquired a new stake in Pediatrix Medical Group in the 4th quarter worth approximately $30,000. Eurizon Capital SGR S.p.A. acquired a new stake in Pediatrix Medical Group in the 4th quarter worth approximately $33,000. Blue Trust Inc. acquired a new stake in Pediatrix Medical Group in the 4th quarter worth approximately $37,000. Finally, TD Private Client Wealth LLC acquired a new stake in Pediatrix Medical Group in the 4th quarter worth approximately $39,000. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Performance

Shares of NYSE MD opened at $23.56 on Thursday. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45. Pediatrix Medical Group, Inc. has a 12 month low of $11.84 and a 12 month high of $24.99. The company has a 50 day simple moving average of $22.58 and a two-hundred day simple moving average of $21.70. The stock has a market cap of $1.93 billion, a price-to-earnings ratio of 11.44 and a beta of 0.69.

Pediatrix Medical Group (NYSE:MD – Get Free Report) last posted its earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. The firm had revenue of $476.20 million during the quarter, compared to analyst estimates of $465.83 million. During the same period in the previous year, the firm earned $0.33 EPS. The business’s quarterly revenue was up 3.9% on a year-over-year basis. As a group, analysts predict that Pediatrix Medical Group, Inc. will post 2.1 earnings per share for the current year.

Insider Activity

In related news, Director Shirley A. Weis sold 36,028 shares of the business’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total value of $855,665.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.80% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Mizuho set a $24.00 price objective on shares of Pediatrix Medical Group in a research note on Friday, May 8th. Weiss Ratings restated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research note on Friday, March 27th. Deutsche Bank Aktiengesellschaft set a $19.00 price objective on shares of Pediatrix Medical Group in a research note on Friday, February 20th. UBS Group lifted their price objective on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. Finally, Truist Financial lifted their price objective on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the company a “hold” rating in a research note on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $22.50.

Read Our Latest Report on Pediatrix Medical Group

About Pediatrix Medical Group

(Free Report)

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.